Seshu Tyagarajan, Ph.D., RAC

Seshu Tyagarajan, Ph.D., RAC

Chief Technical and Development OfficeratCandel Therapeutics· In the 2024 proxy

Seshu Tyagarajan, Ph.D., RAC is Chief Technical and Development Officer of Candel Therapeutics.

Experience

  1. Candel TherapeuticsPublic company · 2 yr
    • Chief Technical and Development Officer2024 – Present · 2 yrStock in role +661%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?